Hikal Q3 Results
- BSE: 524735
- NSE: HIKAL
- ISIN: INE475B01022
- Sector: Biotechnology & Drugs
BSE
189.80
-0.30 (-0.16%)
-0.30 (-0.16%)Volume5.08 K
Updated: Thu 18 Jun, 2026 | 11:06:15
NSE
189.91-0.05 (-0.03%)
-0.05 (-0.03%)Volume1.00 L
Updated: Thu 18 Jun, 2026 | 10:52:08
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Hikal Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 490.80 | 409.70 | 39.23% | 411.78 | 20.06% |
| Depreciation/ Amortization | 41.20 | 31.70 | 0.00% | 28.97 | 24.10% |
| Operating Income | 3.50 | 43.20 | 0.00% | 35.79 | -91.00% |
| Net Income | -5.90 | 18.30 | -83.09% | 16.14 | 0.00% |
| Other Operating Expenses Total | 109.00 | 114.00 | -5.55% | 114.68 | 8.78% |
| Net Income Before Taxes | -9.20 | 24.80 | -80.43% | 21.61 | 0.00% |
| Total Revenue | 494.30 | 452.90 | 55.20% | 447.57 | 10.41% |
| Selling/ General/ Admin Expenses Total | 70.60 | 62.10 | 1.44% | 61.31 | 9.46% |
| Diluted Normalized EPS | 1.53 | 1.48 | 0.00% | 1.31 | 10.04% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.